By Admin at 26 Aug 2016
Aromatase inhibitors are often used to shrink breast tumors prior to surgery, but new research suggests it may be wise to reevaluate the tumor again just prior to surgery to monitor its changes and decide if a new course of treatment would be appropriate.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
